Brief: Kuros Biosciences FY EPS CHF -0.38
13/03/2024 06:13
Mar 13 (Reuters) - Kuros Biosciences FY net income CHF -13.727 million. * FY EPS CHF -0.38 * FY operating income CHF -13.192 million
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million